Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Australia
  4. Australian Stock Exchange
  5. Next Science Limited
  6. News
  7. Summary
    NXS   AU0000041329

NEXT SCIENCE LIMITED

(NXS)
  Report
Delayed Australian Stock Exchange  -  12:10 2022-12-05 am EST
0.6750 AUD   -3.57%
10/27Transcript : Next Science Limited Presents at ShareCafe Small Cap "Hidden Gems" Webinar, Oct-27-2022 09:30 PM
CI
10/19Next Science's Collagen Products Secure Medicare Accreditation in the US; Shares Jump 8%
MT
10/18Next Science Limited Announces the Launch of Topical Collagen Products
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Transcript : Next Science Limited, H1 2022 Earnings Call, Aug 25, 2022

08/24/2022 | 08:01pm EST
Thank you for standing by, and welcome to the Next Science Limited 2022 Half Year Results Conference Call. [Operator Instructions] And now I would like to hand the conference over to Ms. Judith...


ę S&P Capital IQ 2022
All news about NEXT SCIENCE LIMITED
10/27Transcript : Next Science Limited Presents at ShareCafe Small Cap "Hidden Gem..
CI
10/19Next Science's Collagen Products Secure Medicare Accreditation in the US; Shares Jump 8..
MT
10/18Next Science Limited Announces the Launch of Topical Collagen Products
CI
08/26Next Science Secures License for Wound Cleaning Product in Canada
MT
08/25Next Science Limited Announces Health Canada Given Licensing Approval for XPERIENCE
CI
08/24Transcript : Next Science Limited, H1 2022 Earnings Call, Aug 25, 2022
CI
08/24Next Science Limited Reports Earnings Results for the Half Year Ended June 30, 2022
CI
07/25Next Science : Investor Presentation - Q2 2022
PU
05/27Next Science CEO to Resign Before June 30, 2023
MT
05/27Transcript : Next Science Limited - Shareholder/Analyst Call
CI
More news
Financials (USD)
Sales 2022 16,4 M - -
Net income 2022 -7,28 M - -
Net cash 2022 10,8 M - -
P/E ratio 2022 -10,2x
Yield 2022 -
Capitalization 97,6 M 97,6 M -
EV / Sales 2022 5,30x
EV / Sales 2023 2,80x
Nbr of Employees -
Free-Float 47,5%
Chart NEXT SCIENCE LIMITED
Duration : Period :
Next Science Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends NEXT SCIENCE LIMITED
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Last Close Price 0,45 $
Average target price 1,26 $
Spread / Average Target 177%
EPS Revisions
Managers and Directors
Judith Mitchell Chief Executive Officer, Director & MD
Jacqueline Butler Chief Financial Officer
Mark R. Compton Independent Non-Executive Chairman
Matthew Myntti Chief Technology Officer
Jeanne Lee VP-Regulatory Affairs & Clinical Operations
Sector and Competitors
1st jan.Capi. (M$)
NEXT SCIENCE LIMITED-43.78%102
JOHNSON & JOHNSON4.57%467 679
ELI LILLY AND COMPANY35.67%356 089
ABBVIE INC.20.87%289 331
NOVO NORDISK A/S22.04%285 887
PFIZER, INC.-13.78%285 774